Schizophrenia research · 2026
Mediodorsal and pulvinar thalamus reductions across the psychosis spectrum.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zeng Victor, Hoang Dung, Song Seo Ho, Trotti Rebekah, Parker David, Raymond Nicolas, Iska Neha, Del Re Elisabetta C, Coxon Evie, Rychagov Nicole, Adhan Iniya, Nisenson Melanie, Hegde Rachal, Reed Alexandra, Lai Matthew, Ivleva Elena, Hill S Kristian, McDowell Jennifer, Sweeney John, Lizano Paulo, Tamminga Carol, Pearlson Godfrey, Gershon Elliot, Keedy Sarah, Clementz Brett, Keshavan Matcheri
Аннотация
BACKGROUND: Abnormalities in thalamic structure and function are a consistent feature of psychosis spectrum disorders including schizophrenia (SZ), schizoaffective (SAD), and bipolar disorder with psychosis (BDP), yet the extent to which specific thalamic nuclei differ across diagnoses, and how these differences relate to cognition and psychopathology, remains unclear. We examined these questions, focusing on two nuclei - the mediodorsal (MD) and pulvinar (Pu), among individuals with psychosis (n = 2160) in the Bipolar-Schizophrenia Network on Intermediate Phenotypes consortium.
METHODS: Whole thalamus, MD, and Pu were estimated using FreeSurfer. Group comparisons were performed to examine volumetric differences between neurotypical controls (NC) and: (1) traditional diagnostic groups and (2) biologically-defined Biotypes identified through unsupervised clustering of neurophysiological features. Spearman correlations were used to assess the associations between subthalamic nuclei volumes and cognitive performances.
RESULTS: The MD volumes were significantly smaller in individuals with SZ, SAD, BDP and BT1 compared to controls (Cohen's d between -0.17 to -0.37). MD and Pu volumes positively correlated with some cognitive functions, notably in the right MD.
CONCLUSIONS: This is the largest study to date examining thalamic nuclei volumes across both DSM diagnoses and psychosis Biotypes. We demonstrate that MD reductions are transdiagnostic yet most pronounced in BT1, supporting the Biotype framework over traditional nosology. The links between MD volume and cognitive performance suggest that nucleus-specific thalamic markers may help refine mechanistic models and stratify future treatment targets. Multimodal studies integrating electrophysiology and functional imaging are warranted to clarify nuclei-specific contributions to psychosis.
METHODS: Whole thalamus, MD, and Pu were estimated using FreeSurfer. Group comparisons were performed to examine volumetric differences between neurotypical controls (NC) and: (1) traditional diagnostic groups and (2) biologically-defined Biotypes identified through unsupervised clustering of neurophysiological features. Spearman correlations were used to assess the associations between subthalamic nuclei volumes and cognitive performances.
RESULTS: The MD volumes were significantly smaller in individuals with SZ, SAD, BDP and BT1 compared to controls (Cohen's d between -0.17 to -0.37). MD and Pu volumes positively correlated with some cognitive functions, notably in the right MD.
CONCLUSIONS: This is the largest study to date examining thalamic nuclei volumes across both DSM diagnoses and psychosis Biotypes. We demonstrate that MD reductions are transdiagnostic yet most pronounced in BT1, supporting the Biotype framework over traditional nosology. The links between MD volume and cognitive performance suggest that nucleus-specific thalamic markers may help refine mechanistic models and stratify future treatment targets. Multimodal studies integrating electrophysiology and functional imaging are warranted to clarify nuclei-specific contributions to psychosis.